Trial Profile
Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Oct 2012
Price :
$35
*
At a glance
- Drugs House dust mite allergy immunotherapy Laboratorios LETI (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors LETI Pharma GmbH
- 01 Oct 2012 New trial record